QoLiCOL - Quality of Life in Colon Cancer

Last updated: November 3, 2023
Sponsor: Sahlgrenska University Hospital, Sweden
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Colon Cancer

Colon Cancer; Rectal Cancer

Colorectal Cancer

Treatment

There is no intervention, only observation

Clinical Study ID

NCT02530593
QoLiCOL
  • Ages > 18
  • All Genders

Study Summary

All patients presenting at participating hospitals during the recruitment period with a newly diagnosed colon cancer, regardless of stage and planned treatment, will be eligible for inclusion. They will answer a questionnaire on health related quality of life, physical symptoms, functional impairments and socioeconomic status at diagnosis and after 12, 36 months. Clinical data including recurrence, survival, surgical treatment, oncologic result (pathology report) and adjuvant treatment will be collected from the Swedish ColoRectal Cancer Registry (SCRCR)

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Colon cancer newly diagnosed.
  • Planned treatment presented

Exclusion

Exclusion Criteria:

  • No Colon cancer diagnosis,
  • below 18 years of age,
  • no informed consent or withdrawn informed consent.

Study Design

Total Participants: 1500
Treatment Group(s): 1
Primary Treatment: There is no intervention, only observation
Phase:
Study Start date:
June 01, 2015
Estimated Completion Date:
September 30, 2025

Study Description

QoLiCOL is an explorative, prospective, longitudinal, non-interventional, international, multicenter study of health-related quality of life, physical symptoms, functional impairments and socioeconomic burden in colon cancer patients. All patients presenting at participating hospitals during the recruitment period with a newly diagnosed rectal cancer, regardless of stage and planned treatment, will be eligible for inclusion. Patients will be followed for 3 years. They will be asked to answer questionnaires at three different time points during follow-up: at diagnosis and after 12 and 36 months. Clinical data, including recurrence, surgical treatment, oncologic result (pathology report) and adjuvant treatment will be collected from the national quality registry for rectal cancer in Denmark and Sweden. As these registries differ in some areas between the countries, additional data will be collected through short CRF:s.

Connect with a study center

  • Sahlgrenska University Hospital/Östra

    Göteborg, 416 85
    Sweden

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.